Skip to content

Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization

Prevalence of Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01762098
Enrollment
100
Registered
2013-01-07
Start date
2012-11-30
Completion date
2015-05-31
Last updated
2015-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion, Spontaneous, Endometritis, Infertility

Keywords

In vitro fertilization, Hysteroscopy, Endometrial biopsy

Brief summary

Chronic endometritis is a persistent inflammation of the endometrium. Chronic endometritis is asymptomatic or little symptomatic. Sometimes, patient with chronic endometritis can have genital bleeding, pelvic chronic pain, pain during sexual relations, persistent vaginal white loosing. The hysteroscopy can detect the presence or absence of chronic endometritis. Some studies showed that the endometritis could have an impact on the embryo implantation and could explain recurrent miscarriages or repeated embryo implantation failures. The goal of this study is to evaluate the frequency of the chronic endometritis in patients with recurrent miscarriages or repeated embryo implantation failures

Interventions

None listed

Sponsors

Clinique Ovo
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

Group repeated miscarriages * Women aged 18 to 43 years * ≥ 2 miscarriages before 14 weeks of gestation * Genetic (karyotype x2), thrombophilic and endocrine assessment should be completed Group of implantation failure in In-vitro fertilization * Women aged 18 to 45 years * Absence of pregnancy after 3 good quality embryos transferred in women under 35 years and 4 embryos in the 35 years and over.

Exclusion criteria

* Positive pregnancy test * Unexplained bleeding * Incomplete miscarriage assessment * Uterine malformation * Antibiotic treatment during or within one month prior to the biopsy

Design outcomes

Primary

MeasureTime frame
Rate of chronic endometritis1 day

Secondary

MeasureTime frame
Pregnancy rate1 year

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026